Table 2 Demographic data and clinical features of patients beyond the Milan criteria (n = 78) by explant pathology
Recurrence-free (n = 47) | Recurrent (n = 31) | p value | |||
|---|---|---|---|---|---|
Mean ± SD | Range | Mean ± SD | Range | ||
Male sex, n (%) | 41 (87.2) | 30 (96.8) | 0.233 | ||
Age (years) | 56.21 ± 7.62 | 35–68 | 56.00 ± 7.37 | 43–72 | 0.903 |
MELD score | 13.32 ± 7.20 | 5.0–35.0 | 11.58 ± 4.93 | 6.0–25 | 0.244 |
AFP (ng/mL) | 4312.40 ± 25,171.44 | 2.49–170,961.00 | 687.37 ± 166.02 | 2.24–7889.00 | 0.434 |
Blood loss (ml) | 2934.04 ± 3191.81 | 300.0–17,000.0 | 3870.97 ± 4941.79 | 200.0–23,000.0 | 0.312 |
Max HCC size (cm) | 4.13 ± 1.96 | 1.10–10.00 | 6.10 ± 3.41 | 2.10–22.80 | 0.006 |
Total HCC size (cm) | 7.19 ± 4.13 | 1.10–22.70 | 10.21 ± 5.01 | 2.10–22.80 | 0.005 |
HCC number | 3.11 ± 1.88 | 0.0–9.0 | 4.29 ± 3.31 | 1.0–14.0 | 0.077 |
cHC-CC, n (%) | 1 (2.1) | 1 (2.1) | 1.000 | ||
Vascular invasion, n (%) | 11 (23.4) | 13 (41.9) | 0.083 | ||
AFP > 400 (ng/mL), n (%) | 10 (21.3) | 6 (19.4) | 0.837 | ||
Mortality, n (%) | 4 (8.5) | 29 (93.5) | < 0.001 | ||